Startseite › Herzinsuffizienz › Missouri › Kansas City
Klinische Studien zu Herzinsuffizienz in Kansas City, MO
25 Studien zu Herzinsuffizienz suchen Teilnehmer an Standorten in und um Kansas City (im Umkreis von ca. 30 Meilen). Öffnen Sie eine Studie, um Teilnahmevoraussetzungen und Kontaktdaten des Studienteams zu sehen.
Offizieller Studientext (Englisch)
ELEVATE-HFpEF Clinical Study
Teilnehmer gesucht
- Saint Lukes Mid America Heart Institute, Kansas City
Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function
Teilnehmer gesuchtPhase 3
- Research Site, Kansas City
- Research Site, Kansas City
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
Teilnehmer gesuchtPhase 3
- Kansas City VA Medical Center, Kansas City
- North Kansas City Hospital, North Kansas City · 2 mi entfernt
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
Teilnehmer gesuchtPhase 3
- Kansas City VA Medical Center, Kansas City
A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF
Teilnehmer gesuchtPhase 3
- Research Site, Kansas City
Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction
Teilnehmer gesuchtPhase 3
- Saint Luke's Hospital of Kansas City, Kansas City
Barostim-Enabled NEurohormonal Intervention For Improving Treatment of Heart Failure
Teilnehmer gesucht
- Saint Luke's Hospital of Kansas City, Kansas City
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
Teilnehmer gesuchtPhase 3
- Saint Luke's Hospital of Kansas City, Kansas City
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
Teilnehmer gesuchtPhase 3
- Research Site, Kansas City
- Research Site, Kansas City
A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
Teilnehmer gesuchtPhase 3
- Kansas City, MO Investigative Site 10002, Kansas City
A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Failure (CONFIRMATION-HF)
Teilnehmer gesuchtPhase 3
- CON-10002 Kansas City, MO Investigative Site, Kansas City
The WiSE®-UP Study (The WiSE System Utilization & Performance Study)
Teilnehmer gesuchtBeobachtungsstudie
- St. Luke's Hospital of Kansas City, Kansas City
A Study of EDG-15400 in Adults With Heart Failure With Preserved Ejection Fraction (EQUINOX-HFpEF)
Teilnehmer gesuchtPhase 2
- Local Institution - 145, Kansas City
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
Teilnehmer gesuchtBeobachtungsstudie
- Kansas City, Kansas City
A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)
Teilnehmer gesuchtBeobachtungsstudie
- St. Luke's Mid-America Heart Institute, Kansas City
LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2
Teilnehmer gesuchtPhase 3
- Tenax Investigational Site, Kansas City
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
Teilnehmer gesuchtPhase 3
- Clinical Research Consultants, JCCT Co, Kansas City
Assessment of CCM in HF With Higher Ejection Fraction
Teilnehmer gesucht
- St. Lukes Hospital Kansas City (Mid America Heart Institute), Kansas City
A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients With Heart Failure Who Are Intolerant or Not Eligible for Treatment With Steroidal Mineralocorticoid Receptor Antagonists
Teilnehmer gesuchtPhase 3
- FIN-10002 Kansas City, MO Investigational Site, Kansas City
PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III
Teilnehmer gesucht
- St. Lukes/ Mid-American Heart Institute, Kansas City
A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Children and Young Adults With Heart Failure and Left Ventricular Systolic Dysfunction
Teilnehmer gesuchtPhase 3
- Children's Mercy Hospital Kansas City - Cardiology, Kansas City
A Study to Learn More About How Well Finerenone Works, How Safe it is, and How it Moves Into, Through, and Out of the Body Compared to Placebo When Taken With Standard Treatment in Children With Heart Failure and Left Ventricular Systolic Dysfunction
Teilnehmer gesuchtPhase 3
- Children's Mercy Hospital Kansas City - Cardiology, Kansas City
Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
Teilnehmer gesucht
- St. Luke's Hospital, Kansas City
CCM OPEN HF Registry
Teilnehmer gesuchtBeobachtungsstudie
- Saint Luke's Hospital Mid America Heart Institute, Kansas City
- Saint Luke's Hospital of Kansas City, Kansas City
HF2 Registry - Hemodynamic Frontiers in Heart Failure Registry
Teilnehmer gesuchtBeobachtungsstudie
- Saint Luke's Health System, Kansas City
Herzinsuffizienz-Studien in anderen Städten
- New York City, NY51 Studien
- Boston, MA44 Studien
- Dallas, TX42 Studien
- Houston, TX36 Studien
- Cleveland, OH33 Studien
- Chicago, IL31 Studien
- Philadelphia, PA31 Studien
- San Francisco, CA29 Studien
- Durham, NC26 Studien
- St. Louis, MO26 Studien
- Atlanta, GA25 Studien
- Cincinnati, OH24 Studien
Weitere Studien in Kansas City
- Brustkrebs34 Studien
- Nichtkleinzelliges Lungenkarzinom31 Studien
- Krebs (alle Arten)21 Studien
- Lungenkrebs19 Studien
- Kolorektales Karzinom16 Studien
- Metastasierender Krebs15 Studien
- Akute myeloische Leukämie15 Studien
- Prostatakrebs14 Studien
- Eierstockkrebs11 Studien
- Adipositas11 Studien
- Typ-2-Diabetes11 Studien
- Herz-Kreislauf-Erkrankungen11 Studien
Quelle: ClinicalTrials.gov, Daten abgerufen am 06.10.2026. Jede Studie legt ihre eigenen Teilnahmevoraussetzungen fest; das Studienteam entscheidet über die Zulassung.